Skip to main content
Erschienen in: Journal of Thrombosis and Thrombolysis 4/2020

17.03.2020

Severe high-molecular-weight kininogen deficiency due to a homozygous c.1456C > T nonsense variant in a large Chinese family

verfasst von: Jing Yang, Liankai Fan, Yacui Qiao, Yongqiang Zhao, Tienan Zhu

Erschienen in: Journal of Thrombosis and Thrombolysis | Ausgabe 4/2020

Einloggen, um Zugang zu erhalten

Abstract

High-molecular-weight kininogen (HMWK) deficiency is a very rare hereditary disorder caused by a defect of Kininogen-1 gene (KGN1). A 67-year-old asymptomatic male with an isolated prolonged activated partial thromboplastin time (aPTT) was recognized to have HMWK deficiency. The propositus had less than 1% HMWK procoagulant activity. The plasma HMWK procoagulant activities of his 2 younger sisters were 1.1% and less than 1%, respectively. Prekallikrein (PK) activity was also reduced in the propositus and two of his younger sisters with severe HMWK deficiency. Genetic testing to identify the KGN1 mutation provides a precise diagnosis for the patient and other family members. This Chinese family has a novel KGN1 nonsense variant, C to T, at nucleotide position 1456 leading to a stop codon in position 486 (p. Gln486*).
Literatur
1.
Zurück zum Zitat Schmaier AH (2016) The contact activation and kallikrein/kinin systems: pathophysiologic and physiologic activities. J Thromb Haemost 14(1):28–39CrossRef Schmaier AH (2016) The contact activation and kallikrein/kinin systems: pathophysiologic and physiologic activities. J Thromb Haemost 14(1):28–39CrossRef
2.
Zurück zum Zitat Saito H, Ratnoff OD, Waldmann R, Abraham JP (1975) Fitzgerald trait: deficiency of a hitherto unrecognized agent, fitzgerald factor, participating in surface-mediated reactions of clotting, fibrinolysis, generation of kinins, and the property of diluted plasma enhancing vascular permeability (PF/Dil). J Clin Invest 55(5):1082–1089CrossRef Saito H, Ratnoff OD, Waldmann R, Abraham JP (1975) Fitzgerald trait: deficiency of a hitherto unrecognized agent, fitzgerald factor, participating in surface-mediated reactions of clotting, fibrinolysis, generation of kinins, and the property of diluted plasma enhancing vascular permeability (PF/Dil). J Clin Invest 55(5):1082–1089CrossRef
3.
Zurück zum Zitat Waldmann R, Abraham JP, Rebuck JW, Caldwell J, Saito H, Ratnoff OD (1975) Fitzgerald factor: a hitherto unrecognised coagulation factor. Lancet 1(7913):949–951CrossRef Waldmann R, Abraham JP, Rebuck JW, Caldwell J, Saito H, Ratnoff OD (1975) Fitzgerald factor: a hitherto unrecognised coagulation factor. Lancet 1(7913):949–951CrossRef
4.
Zurück zum Zitat Colman RW, Bagdasarian A, Talamo RC, Scott CF, Seavey M, Guimaraes JA, Pierce JV, Kaplan AP (1975) Williams trait. Human kininogen deficiency with diminished levels of plasminogen proactivator and prekallikrein associated with abnormalities of the Hageman factor-dependent pathways. J Clin Invest 56(6):1650–1662CrossRef Colman RW, Bagdasarian A, Talamo RC, Scott CF, Seavey M, Guimaraes JA, Pierce JV, Kaplan AP (1975) Williams trait. Human kininogen deficiency with diminished levels of plasminogen proactivator and prekallikrein associated with abnormalities of the Hageman factor-dependent pathways. J Clin Invest 56(6):1650–1662CrossRef
5.
Zurück zum Zitat Wuepper KD, Miller DR, Lacombe MJ (1975) Flaujeac trait. Deficiency of human plasma kininogen. J Clin Invest 56(6):1663–1672CrossRef Wuepper KD, Miller DR, Lacombe MJ (1975) Flaujeac trait. Deficiency of human plasma kininogen. J Clin Invest 56(6):1663–1672CrossRef
6.
Zurück zum Zitat Lefrere JJ, Horellou MH, Gozin D, Conard J, Muller JY, Clark M, Soulier JP, Samama M (1986) A new case of high-molecular-weight kininogen inherited deficiency. Am J Hematol 22(4):415–419CrossRef Lefrere JJ, Horellou MH, Gozin D, Conard J, Muller JY, Clark M, Soulier JP, Samama M (1986) A new case of high-molecular-weight kininogen inherited deficiency. Am J Hematol 22(4):415–419CrossRef
7.
Zurück zum Zitat Vicente V, Alberca I, Gonzalez R, Alegre A, Redondo C, Moro J (1986) New congenital deficiency of high molecular weight kininogen and prekallikrein (Fitzgerald trait). Study of response to DDAVP and venous occlusion. Haematologia (Budap) 19(1):41–48 Vicente V, Alberca I, Gonzalez R, Alegre A, Redondo C, Moro J (1986) New congenital deficiency of high molecular weight kininogen and prekallikrein (Fitzgerald trait). Study of response to DDAVP and venous occlusion. Haematologia (Budap) 19(1):41–48
8.
Zurück zum Zitat Davidson SJ, Burman JF, Rutherford LC, Keogh BF, Yacoub MH (2001) High molecular weight kininogen deficiency: a patient who underwent cardiac surgery. Thromb Haemost 85(2):195–197CrossRef Davidson SJ, Burman JF, Rutherford LC, Keogh BF, Yacoub MH (2001) High molecular weight kininogen deficiency: a patient who underwent cardiac surgery. Thromb Haemost 85(2):195–197CrossRef
9.
Zurück zum Zitat Krijanovski Y, Proulle V, Mahdi F, Dreyfus M, Muller-Esterl W, Schmaier AH (2003) Characterization of molecular defects of Fitzgerald trait and another novel high-molecular-weight kininogen-deficient patient: insights into structural requirements for kininogen expression. Blood 101(11):4430–4436CrossRef Krijanovski Y, Proulle V, Mahdi F, Dreyfus M, Muller-Esterl W, Schmaier AH (2003) Characterization of molecular defects of Fitzgerald trait and another novel high-molecular-weight kininogen-deficient patient: insights into structural requirements for kininogen expression. Blood 101(11):4430–4436CrossRef
10.
Zurück zum Zitat Hayashi H, Ishimaru F, Fujita T, Tsurumi N, Tsuda T, Kimura I (1990) Molecular genetic survey of five Japanese families with high-molecular-weight kininogen deficiency. Blood 75(6):1296–1304CrossRef Hayashi H, Ishimaru F, Fujita T, Tsurumi N, Tsuda T, Kimura I (1990) Molecular genetic survey of five Japanese families with high-molecular-weight kininogen deficiency. Blood 75(6):1296–1304CrossRef
11.
Zurück zum Zitat Fukushima N, Itamura H, Wada H, Ikejiri M, Igarashi Y, Masaki H, Sano M, Komiyama Y, Ichinohe T, Kimura S (2014) A novel frameshift mutation in exon 4 causing a deficiency of high-molecular-weight kininogen in a patient with splenic infarction. Intern Med 53(3):253–257CrossRef Fukushima N, Itamura H, Wada H, Ikejiri M, Igarashi Y, Masaki H, Sano M, Komiyama Y, Ichinohe T, Kimura S (2014) A novel frameshift mutation in exon 4 causing a deficiency of high-molecular-weight kininogen in a patient with splenic infarction. Intern Med 53(3):253–257CrossRef
12.
Zurück zum Zitat Jeong D, Goo JY, Kim HK, Chong SY, Kang MS (2020) The first Korean case of high-molecular-weight kininogen deficiency, with a novel variant, c.488delG, in the KNG1 gene. Ann Lab Med 40(3):264–266CrossRef Jeong D, Goo JY, Kim HK, Chong SY, Kang MS (2020) The first Korean case of high-molecular-weight kininogen deficiency, with a novel variant, c.488delG, in the KNG1 gene. Ann Lab Med 40(3):264–266CrossRef
13.
Zurück zum Zitat Jin ZB, Huang XF, Lv JN, Xiang L, Li DQ, Chen J, Huang C, Wu J, Lu F, Qu J (2014) SLC7A14 linked to autosomal recessive retinitis pigmentosa. Nat Commun 5:3517CrossRef Jin ZB, Huang XF, Lv JN, Xiang L, Li DQ, Chen J, Huang C, Wu J, Lu F, Qu J (2014) SLC7A14 linked to autosomal recessive retinitis pigmentosa. Nat Commun 5:3517CrossRef
14.
Zurück zum Zitat Donaldson VH, Kleniewski J, Saito H, Sayed JK (1977) Prekallikrein deficiency in a kindred with kininogen deficiency and Fitzgerald trait clotting defect. Evidence that high molecular weight kininogen and prekallikrein exist as a complex in normal human plasma. J Clin Invest 60(3):571–583CrossRef Donaldson VH, Kleniewski J, Saito H, Sayed JK (1977) Prekallikrein deficiency in a kindred with kininogen deficiency and Fitzgerald trait clotting defect. Evidence that high molecular weight kininogen and prekallikrein exist as a complex in normal human plasma. J Clin Invest 60(3):571–583CrossRef
15.
Zurück zum Zitat Bjorkqvist J, Jamsa A, Renne T (2013) Plasma kallikrein: the bradykinin-producing enzyme. Thromb Haemost 110(3):399–407CrossRef Bjorkqvist J, Jamsa A, Renne T (2013) Plasma kallikrein: the bradykinin-producing enzyme. Thromb Haemost 110(3):399–407CrossRef
16.
Zurück zum Zitat Cagliani R, Forni D, Riva S, Pozzoli U, Colleoni M, Bresolin N, Clerici M, Sironi M (2013) Evolutionary analysis of the contact system indicates that kininogen evolved adaptively in mammals and in human populations. Mol Biol Evol 30(6):1397–1408CrossRef Cagliani R, Forni D, Riva S, Pozzoli U, Colleoni M, Bresolin N, Clerici M, Sironi M (2013) Evolutionary analysis of the contact system indicates that kininogen evolved adaptively in mammals and in human populations. Mol Biol Evol 30(6):1397–1408CrossRef
17.
Zurück zum Zitat Amiral J, Seghatchian J (2019) The contact system at the crossroads of various key patho- physiological functions: update on present understanding, laboratory exploration and future perspectives. Transfus Apher Sci 58(2):216–222CrossRef Amiral J, Seghatchian J (2019) The contact system at the crossroads of various key patho- physiological functions: update on present understanding, laboratory exploration and future perspectives. Transfus Apher Sci 58(2):216–222CrossRef
18.
Zurück zum Zitat Colman RW, Schmaier AH (1997) Contact system: a vascular biology modulator with anticoagulant, profibrinolytic, antiadhesive, and proinflammatory attributes. Blood 90(10):3819–3843CrossRef Colman RW, Schmaier AH (1997) Contact system: a vascular biology modulator with anticoagulant, profibrinolytic, antiadhesive, and proinflammatory attributes. Blood 90(10):3819–3843CrossRef
19.
Zurück zum Zitat Scott CF, Colman RW (1980) Function and immunochemistry of prekallikrein-high molecular weight kininogen complex in plasma. J Clin Invest 65(2):413–421CrossRef Scott CF, Colman RW (1980) Function and immunochemistry of prekallikrein-high molecular weight kininogen complex in plasma. J Clin Invest 65(2):413–421CrossRef
20.
Zurück zum Zitat Renne T, Dedio J, Meijers JC, Chung D, Muller-Esterl W (1999) Mapping of the discontinuous H-kininogen binding site of plasma prekallikrein. Evidence for a critical role of apple domain-2. J Biol Chem 274(36):25777–25784CrossRef Renne T, Dedio J, Meijers JC, Chung D, Muller-Esterl W (1999) Mapping of the discontinuous H-kininogen binding site of plasma prekallikrein. Evidence for a critical role of apple domain-2. J Biol Chem 274(36):25777–25784CrossRef
21.
Zurück zum Zitat Folsom AR, Tang W, Basu S, Misialek JR, Couper D, Heckbert SR, Cushman M (2019) Plasma concentrations of high molecular weight kininogen and prekallikrein and venous thromboembolism incidence in the general population. Thromb Haemost 119(5):834–843CrossRef Folsom AR, Tang W, Basu S, Misialek JR, Couper D, Heckbert SR, Cushman M (2019) Plasma concentrations of high molecular weight kininogen and prekallikrein and venous thromboembolism incidence in the general population. Thromb Haemost 119(5):834–843CrossRef
22.
Zurück zum Zitat Cheung PP, Kunapuli SP, Scott CF, Wachtfogel YT, Colman RW (1993) Genetic basis of total kininogen deficiency in Williams’ trait. J Biol Chem 268(31):23361–23365PubMed Cheung PP, Kunapuli SP, Scott CF, Wachtfogel YT, Colman RW (1993) Genetic basis of total kininogen deficiency in Williams’ trait. J Biol Chem 268(31):23361–23365PubMed
23.
Zurück zum Zitat Merkulov S, Zhang WM, Komar AA, Schmaier AH, Barnes E, Zhou Y, Lu X, Iwaki T, Castellino FJ, Luo G et al (2008) Deletion of murine kininogen gene 1 (mKng1) causes loss of plasma kininogen and delays thrombosis. Blood 111(3):1274–1281CrossRef Merkulov S, Zhang WM, Komar AA, Schmaier AH, Barnes E, Zhou Y, Lu X, Iwaki T, Castellino FJ, Luo G et al (2008) Deletion of murine kininogen gene 1 (mKng1) causes loss of plasma kininogen and delays thrombosis. Blood 111(3):1274–1281CrossRef
24.
Zurück zum Zitat Langhauser F, Gob E, Kraft P, Geis C, Schmitt J, Brede M, Gobel K, Helluy X, Pham M, Bendszus M et al (2012) Kininogen deficiency protects from ischemic neurodegeneration in mice by reducing thrombosis, blood-brain barrier damage, and inflammation. Blood 120(19):4082–4092CrossRef Langhauser F, Gob E, Kraft P, Geis C, Schmitt J, Brede M, Gobel K, Helluy X, Pham M, Bendszus M et al (2012) Kininogen deficiency protects from ischemic neurodegeneration in mice by reducing thrombosis, blood-brain barrier damage, and inflammation. Blood 120(19):4082–4092CrossRef
Metadaten
Titel
Severe high-molecular-weight kininogen deficiency due to a homozygous c.1456C > T nonsense variant in a large Chinese family
verfasst von
Jing Yang
Liankai Fan
Yacui Qiao
Yongqiang Zhao
Tienan Zhu
Publikationsdatum
17.03.2020
Verlag
Springer US
Erschienen in
Journal of Thrombosis and Thrombolysis / Ausgabe 4/2020
Print ISSN: 0929-5305
Elektronische ISSN: 1573-742X
DOI
https://doi.org/10.1007/s11239-020-02088-6

Weitere Artikel der Ausgabe 4/2020

Journal of Thrombosis and Thrombolysis 4/2020 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.